Skip to content
Screener

Maravai LifeSciences Holdings, Inc. MRVI FX & Other Adjustments

FX & Other Adjustments at other companies

Repligen logo
RepligenRGEN
$2.69M+108%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$6.84M-111%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
——
Revvity logo
RevvityRVTY
——

Segments

By segment

See full
TriLink$228K—
Cygnus$0—

Other financials

Income statement

See full
Revenue$51.4M+8.5%
Gross profit$20.7M+166%
Operating income-$15.1M+77.2%
Net income-$12.4M+68.6%
EPS (diluted)-$0.08+70.4%

Balance sheet

See full
Cash & equivalents$70.6M-73.8%
Total debt$176.7M-52.4%
Total equity$204.6M-23.0%
Total assets$603.7M-32.7%

Cash flow

See full
Operating cash flow$4.0M+139%
CapEx$370.0K-87.1%
Free cash flow$3.6M+128%

Valuation

See full
Market cap$918.96M+210%
Enterprise value$1.03B+158%
P/S4.4×+3.1×

Profitability

See full
Gross margin34.9%+4.4pp
Operating margin-56.1%-21.3pp
Net margin-37.1%-13.6pp
FCF margin-17.2%—

Returns & leverage

See full
Return on equity-32.9%-9.4pp
Debt / equity0.9×-0.5×
Current ratio4.1×-1.1×